Paris: French authorities are set to rule that below 55s who obtained a primary injection of the AstraZeneca COVID-19 vaccine will be given a jab from a unique producer for his or her second dose, Well being Minister Olivier Veran stated on Friday.
France’s nationwide well being authority HAS final month stated that the AstraZeneca vaccine ought to solely be given to these aged 55 and over, as a result of experiences of doubtless lethal blood clots in a really small variety of these youthful individuals vaccinated.
Officers in France initially stated that these given the AstraZeneca jab in a primary dose ought to go forward with the second jab even when aged below 55, however Veran indicated that the HAS would change the recommendation.
“This may usually be confirmed right this moment, it’s completely logical,” stated Veran, with the HAS resulting from give a information convention at 0800 GMT.
France has been injecting healthworkers as a precedence group within the vaccination drive, that means that many youthful individuals have already obtained the AstraZeneca jab resulting from their work.
As Veran famous, they included the minister himself, a neurologist aged 41, who was given the AstraZeneca vaccine dwell on tv on February 8.
“It’s fully constant to say that we don’t advocate the AstraZeneca vaccine to individuals below 55 years of age whereas we be taught extra,” he stated.
“Subsequently, in case you have obtained a primary injection and are below 55 years outdated, you’ll be supplied one other vaccine 12 weeks after the primary injection,” he added.
Europe’s medicines regulator stated this week the AstraZeneca vaccine might trigger very uncommon blood clots amongst some recipients, prompting a number of international locations to to scale up restrictions on the jab.
There are a number of medical trials underway trying on the efficacy of mixing two kinds of coronavirus vaccine – testing the method often called heterologous prime-boosting.
Specialists say the speculation is sound and, as with another illnesses, it might assist convey efficient immunity.
“Based mostly on earlier research which mix totally different vaccine sorts, a mix of the AZ and Pfizer vaccines is prone to be secure nevertheless it’s essential that that is examined within the context of a medical vaccine trial,” stated Helen Fletcher, professor of Immunology on the London Faculty of Hygiene and Tropical Medication.